Guggenheim S&P 500® Equal Weight Health Care ETF
NAV $156.32
Change $0.47 | 0.30%
As Of 8/26/16

Investment Objectives

Seeks to replicate as closely as possible, before fees and expenses, the performance of the S&P 500 Equal Weight Index Health Care.

Net Asset Value

as of 8/26/16
NAV  $156.32
Change $0.47 | 0.30%


Ticker RYH
CUSIP 78355W841
Asset Class Sector
Inception Date 11/1/06
Gross Expense Ratio 0.40%
Net Expense Ratio 0.40%
Related Index Ticker S35
Investment Adviser Security Investors, LLC.
Distributor Guggenheim Funds Distributors, LLC.


as of 8/26/16
Volume 9,404
Last Sale Price $156.34
52-Week Range $161.10 / $132.97
Shares Outstanding 3,400,000
Total Net Assets $531,475,442.28

Overall Morningstar RatingTM *

as of 6/30/16

Among Health Funds

This Fund was rated, based on its risk-adjusted returns, 4 stars for 3 years, 4 stars for 5 years, and 4 stars Overall out of 22, 19, and 22 Health funds, respectively.

Market Close

as of 8/26/16
Close  $156.34
Change $0.41 | 0.26%
High | Low $157.03 | $155.41
Bid/Ask Midpoint  $156.35
Premium / Discount  0.02%

Historical Bid/Ask Midpoint to NAV

as of 8/26/16
  Days % of Total Days
Premium 1084 43.87%
Discount 1150 46.54%
Equal to NAV 237 9.59%
Total 2471 100.00%


as of 8/26/16
Number of Stocks 57
Return on Equity (quarterly 6/30/16) 19.97%
Price to Earning (P/E) 22.27
Price to Book (P/B) 3.06
Dividend Amount $0.09
Ex-Dividend Date N/A


as of 7/29/16
Standard Deviation Sharpe Ratio Beta R-Squared
12.60 1.38 1.00 99.85


Standard Deviation A statistical measure of the historical volatility of an investment, computed using 36 monthly returns. More generally, a measure of the extent to which numbers are spread around their average. The higher the number, the more volatility is to be expected.
Sharpe Ratio A risk-adjusted measure developed by William F. Sharpe, calculated using standard deviation and excess return to determine reward per unit of risk. The higher the Sharpe ratio, the better the fund's risk-adjusted performance.
Beta Beta is a statistical measure of volatility relative to the overall market, usually the S&P 500. A positive beta indicates movement in the same direction as the market, while a negative beta indicates movement inverse to the market. Beta for the market is generally considered to be 1. A beta above 1 or below -1 indicates more volatility than the market. A beta between 1 to -1 indicates less volatility than the market.
A measurement of how closely an investment's performance correlates with the performance of a benchmark, such as the S&P 500, and thus a measurement of what portion of its performance may be explained by the performance of the overall market or index. Values for R-squared range from 0 to 100, where 0 indicates no correlation and 100 indicates perfect correlation.
Return on Equity Measures a company’s profitability by demonstrating how much profit a company generates with money invested by shareholders. It is calculated by dividing a company’s 12 month net income by shareholder equity and is expressed as a percentage.
Price to Earns (P/E) The weighted average of each individual stock’s P/E ratio. The P/E ratio of a stock is calculated by dividing the current price of the stock by its trailing 12 month’s earnings per share.
Price to Book (P/B) The market price of a stock divided by the book value per share.

NAV is the price per share at which each Fund issues and redeems shares. The net asset value per share for each Fund is determined once daily as of the close of the listing exchange, usually 4:00 p.m. Eastern time, each day the listing exchange is open for trading. NAV per share is determined by dividing the value of the Fund’s portfolio securities, cash and other assets (including accrued interest), less all liabilities (including accrued expenses), by the total number of shares outstanding.

The closing price is the price of the last reported trade on any exchange on which the Fund trades before the market closes, usually at 4 pm Eastern time.

The bid/ask midpoint is the midpoint of the highest bid and lowest offer on the listing exchange at the time that the NAV is calculated, usually 4 pm Eastern time.

The premium/discount is the amount the Fund is trading higher (“premium”) or lower (“discount”) to its NAV, expressed as a percentage of its bid/ask midpoint to its NAV. A positive number indicates it’s trading at premium and a negative number indicates it’s trading at a discount.


as of 8/26/2016
Total Assets $531,475,442
Number of Stocks 57
Percent Stock 99.89%
Percent Cash / Other 0.11%

Sectors / Industries

as of 8/26/16


as of 8/26/16

Security Name Ticker Shares
% of Net Assets Sector / Industry
ENDO INETERNATIONAL PLC ENDP 547,255 $11,508,772.65 2.17% Pharmaceuticals
MALLINCKRODT PLC MNK 150,889 $11,304,603.88 2.13% Pharmaceuticals
BIOGEN IDEC, INC. BIIB 36,639 $11,291,040.63 2.12% Biotechnology
ILLUMINA INC ILMN 63,682 $10,966,677.22 2.06% Life Sciences Tools & Services
CERNER CORPORATION CERN 162,176 $10,483,056.64 1.97% Health Care Technology
WATERS CORPORATION WAT 65,333 $10,336,333.93 1.94% Life Sciences Tools & Services
HOLOGIC, INC. HOLX 264,169 $10,249,757.20 1.93% Health Care Equipment & Supplies
EDWARDS LIFESCIENCES CORP EW 88,834 $10,239,006.84 1.93% Health Care Equipment & Supplies
AMERISOURCEBERGEN CORP ABC 117,952 $10,114,384.00 1.90% Health Care Providers & Services
ABBOTT LABORATORIES ABT 234,862 $10,094,368.76 1.90% Health Care Equipment & Supplies
VARIAN MEDICAL SYSTEMS IN VAR 105,727 $10,083,183.99 1.90% Health Care Equipment & Supplies
AMGEN INC. AMGN 58,266 $10,020,004.02 1.89% Biotechnology
MERCK & COMPANY, INC. MRK 158,754 $9,977,688.90 1.88% Pharmaceuticals
ZIMMER BIOMET HOLDINGS IN ZBH 75,639 $9,796,006.89 1.84% Health Care Equipment & Supplies
REGENERON PHARMACEUTICALS REGN 24,237 $9,766,783.89 1.84% Biotechnology
QUEST DIAGNOSTICS, INC. DGX 116,445 $9,662,606.10 1.82% Health Care Providers & Services
ZOETIS INC ZTS 190,305 $9,659,881.80 1.82% Pharmaceuticals
INTUITIVE SURGICAL, INC. ISRG 14,057 $9,633,121.53 1.81% Health Care Equipment & Supplies
VERTEX PHARMACEUTICALS VRTX 98,576 $9,570,743.84 1.80% Biotechnology
BAXTER INTERNATIONAL BAX 202,710 $9,563,857.80 1.80% Health Care Equipment & Supplies
ABBVIE INC ABBV 147,844 $9,552,200.84 1.80% Biotechnology
ELI LILLY & COMPANY LLY 121,955 $9,541,759.20 1.80% Pharmaceuticals
CELGENE CORPORATION CELG 87,636 $9,533,920.44 1.79% Biotechnology
DANAHER CORPORATION DHR 116,592 $9,467,270.40 1.78% Health Care Equipment & Supplies
LABORATORY CORP OF AMERIC LH 69,215 $9,416,008.60 1.77% Health Care Providers & Services
AGILENT TECHNOLOGIES, INC A 198,823 $9,408,304.36 1.77% Life Sciences Tools & Services
BOSTON SCIENTIFIC CORP BSX 391,776 $9,390,870.72 1.77% Health Care Equipment & Supplies
BECTON DICKINSON & CO BDX 53,273 $9,347,813.31 1.76% Health Care Equipment & Supplies
JOHNSON & JOHNSON JNJ 77,074 $9,174,888.96 1.73% Pharmaceuticals
MEDTRONIC PLC MDT 105,237 $9,113,524.20 1.71% Health Care Equipment & Supplies
CARDINAL HEALTH, INC. CAH 114,841 $9,112,633.35 1.71% Health Care Providers & Services
ST. JUDE MEDICAL INC. STJ 116,595 $9,095,575.95 1.71% Health Care Equipment & Supplies
PERKINELMER PKI 167,974 $9,082,354.18 1.71% Life Sciences Tools & Services
THERMO FISHER SCIENTIFIC TMO 59,412 $9,052,012.32 1.70% Life Sciences Tools & Services
STRYKER CORP SYK 78,725 $9,009,289.00 1.70% Health Care Equipment & Supplies
CIGNA CORPORATION CI 70,415 $8,988,474.75 1.69% Health Care Providers & Services
CENTENE CORP CNC 132,783 $8,984,097.78 1.69% Health Care Providers & Services
ALLERGAN PLC AGN 37,432 $8,906,195.76 1.68% Pharmaceuticals
PFIZER INC PFE 255,560 $8,898,599.20 1.67% Pharmaceuticals
MCKESSON CORPORATION MCK 48,625 $8,888,163.75 1.67% Health Care Providers & Services
UNITEDHEALTH GROUP INC. UNH 64,769 $8,848,740.78 1.66% Health Care Providers & Services
AETNA INC AET 74,828 $8,772,086.44 1.65% Health Care Providers & Services
MYLAN NV MYL 202,530 $8,714,865.90 1.64% Pharmaceuticals
DENTSPLY SIRONA, NC. XRAY 141,779 $8,699,559.44 1.64% Health Care Equipment & Supplies
C.R. BARD, INC. BCR 40,016 $8,686,273.12 1.63% Health Care Equipment & Supplies
ALEXION PHARMACEUTICALS I ALXN 66,504 $8,620,913.52 1.62% Biotechnology
EXPRESS SCRIPTS HLDGS ESRX 118,804 $8,590,717.24 1.62% Health Care Providers & Services
ANTHEM INC. ANTM 68,569 $8,567,010.86 1.61% Health Care Providers & Services
HUMANA, INC. HUM 48,286 $8,564,970.68 1.61% Health Care Providers & Services
GILEAD SCIENCES, INC. GILD 106,792 $8,518,797.84 1.60% Biotechnology
HCA HOLDINGS INC HCA 113,370 $8,418,856.20 1.58% Health Care Providers & Services
PATTERSON COS INC PDCO 181,827 $8,398,589.13 1.58% Health Care Providers & Services
HENRY SCHEIN, INC. HSIC 50,565 $8,260,298.40 1.55% Health Care Providers & Services
PERRIGO COMPANY PRGO 91,549 $8,112,156.89 1.53% Pharmaceuticals
UNIVERSAL HEALTH SERVICES UHS 66,721 $7,969,823.45 1.50% Health Care Providers & Services
DAVITA, INC DVA 118,542 $7,548,754.56 1.42% Health Care Providers & Services
BRISTOL MYERS SQUIBB CO BMY 124,140 $7,295,707.80 1.37% Pharmaceuticals


*Morningstar category is based on the underlying securities of the ETF and not the objective. The Morningstar Rating™ is provided for those exchange-traded funds (“ETFs”) with at least a three-year history. Ratings are based on the ETF’s Morningstar Risk-Adjusted Return measure which accounts for variation in monthly performance, placing more emphasis on downward variations and rewarding consistent performance. An ETF’s risk-adjusted return includes a brokerage commission estimate. This estimate is intended to reflect what an average investor would pay when buying or selling an ETF. PLEASE NOTE, this estimate is subject to change and the actual brokerage commission an investor pays may be higher or lower than this estimate. Morningstar compares each ETF’s risk-adjusted return to the open-end mutual fund rating breakpoints for that category. Consistent with the open-end mutual fund ratings, the top 10% of ETFs in each category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars and the bottom 10% receive 1 star. The overall rating for an ETF is based on a weighted average of the time-period ratings (e.g., the ETF’s 3-, 5-, and 10-year rating). The determination of an ETF’s rating does not affect the retail open end mutual fund data published by Morningstar. Past performance is no guarantee of future results.

© 2016 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

Performance displayed represents past performance, which is no guarantee of future results. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Total returns reflect the reinvestment of all dividends. Current performance may be lower or higher than the performance data quoted. For up-to-date fund performance, including performance current to the most recent month-end, please visit the ETF performance page. ETFs are subject to third party transaction fees/commissions. Net asset value (NAV) is calculated by subtracting total liabilities from total assets, then dividing by the number of shares outstanding. Market close is the last price at which shares are traded. Fund shares may trade at, above or below NAV. For additional information, see the fund’s prospectus.

Performance results for periods under one year are short-term and may not provide an adequate basis for evaluating the performance potential of the fund over varying market conditions or economic cycles.

Sector funds may not be suitable for all investors. Investing in sector funds is more volatile than investing in broadly diversified funds, as there is a greater risk due to the concentration of the funds' holdings in issuers of similar offerings. Guggenheim Investment Equal Weight ETFs may not be suitable for all investors. Investment returns and principal value will fluctuate so that when shares are redeemed, they may be worth more or less than original cost. Most investors will also incur customary brokerage commissions when buying or selling shares of an ETF. Investments in securities are subject to market risks that may cause their prices to fluctuate over time. Please review a prospectus carefully for more information of the risks associated with each ETF.

Fund data is subject to change on a daily basis.

Composition is subject to change. Information provided is for illustration purposes only and may not reflect current investments by the fund. Referenced companies are not affiliated with Guggenheim Investments and Guggenheim Investments does not sponsor, endorse, sell or promote the referenced companies.

Standard & Poor's® and S&P® are registered trademarks of Standard & Poor's Financial Services LLC, a subsidiary of McGraw Hill Financial, Inc., and have been licensed for use by Guggenheim Investments and its affiliates. Dow Jones® is a registered trademark of Dow Jones Trademark Holdings LLC. S&P Dow Jones Indices LLC (together with its affiliates, "S&P") does not make investment recommendations, and S&P does not sponsor, endorse, sell or promote the product. S&P makes no representation or warranty regarding the advisability of investing in the product. Past performance of an index is not a guarantee of future results.

Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objectives, risks, charges, expenses and other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or contact us.

Guggenheim Investments represents the investment management businesses of Guggenheim Partners, LLC ("Guggenheim"), which includes Security Investors, LLC ("SI"), Guggenheim Funds Investment Advisors, LLC, ("GFIA") and Guggenheim Partners Investment Management ("GPIM") the investment advisers to the referenced funds. Securities offered through Guggenheim Funds Distributors, LLC, an affiliate of Guggenheim, SI, GFIA and GPIM.


Subscribe to Perspectives

©2016 Guggenheim Investments. All Rights Reserved.

Research our firm with FINRA Broker Check.

• Not FDIC Insured • No Bank Guarantee • May Lose Value